EUVIMEDOpdag EUVIMED
Crossref

Boronic Chalcones as Antibacterial Adjuvants: Antibacterial Activity, Synergy With Antibiotics and Siderophore Conjugation

Mariana C Almeida iD, Juliana Romano Lopes iD, Andreia Palmeira, Inês Costa iD, Renata Silva iD, Paulo M da Costa, Maria Emília Sousa iD, Jean Leandro Dos Santos, Diana I S P Resende iD

ChemMedChem · 2026-11-12 · 21 (21)

DOI: 10.1002/cmdc.70565 ↗

At a glance

Journal article in ChemMedChem, published online on 2026-11-10. Written by Mariana C Almeida and 8 co-authors. Institution: Laboratório de Química Orgânica e Farmacêutica, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal. Major MEDLINE topics: Anti-Bacterial Agents, Siderophores, Boronic Acids, Chalcones. 78 references. Funded by: Fundação para a Ciência e a Tecnologia, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação de Amparo à Pesquisa do Estado de São Paulo.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Antibacterial resistance has reached critical levels and constitutes a global health emergency. Boronic acid derivatives have emerged as promising antibacterial adjuvants, particularly due to their β‐lactamase inhibitory potential. Given the growing interest in siderophore‐mediated drug delivery as a strategy to enhance antibacterial efficacy, two novel conjugates combining a boronic acid‐chalcone derivative with monocatechol siderophore mimetics were synthesized. First, a series of boronic acid‐containing chalcones was screened against a panel of bacterial species, including reference strains and clinical isolates. The potential synergistic effects of these compounds in combination with clinically relevant antibiotics, namely oxacillin, vancomycin, and cefotaxime, were also assessed. Five compounds (4–8) exhibited antibacterial activity against Staphylococcus aureus and Enterococcus faecalis (MICs = 16–64 µg/mL) and demonstrated synergistic effects with oxacillin against methicillin‐resistant S. aureus (MRSA). Docking studies targeting both the active and allosteric sites of PBP2a were also performed for the most promising compounds, allowing the identification of plausible binding modes at both sites. Two boronic‐chalcone conjugates (16–17) with siderophore mimetics were prepared by direct esterification and demonstrated slight improvements in activity against S . aureus . A preliminary cytotoxicity assessment of all compounds indicated a limited selectivity window, highlighting the need for further structural optimization.

Subjects

MeSH terms (MEDLINE)

Anti-Bacterial AgentsSiderophoresBoronic AcidsChalconesMicrobial Sensitivity TestsStructure-Activity RelationshipStaphylococcus aureusHumansEnterococcus faecalisMolecular StructureDrug SynergismMolecular Docking SimulationDose-Response Relationship, Drug

Author keywords

antibacterial activityboronic acidschalconedrug deliverysiderophores

Substances

Anti-Bacterial AgentsSiderophoresBoronic AcidsChalcones

Authors and institutions

  • Laboratório de Química Orgânica e Farmacêutica, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal.
  • CIIMAR/CIMAR LA, Centro Interdisciplinar de Investigação Marinha e Ambiental, Universidade do Porto, Matosinhos, Portugal.
  • School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, São Paulo, Brazil.
  • Laboratório Associado i4HB-Instituto para a Saúde e Bioeconomia, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal.
  • UCIBIO, Laboratório de Toxicologia, Departamento de Ciências biológicas, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal.
  • ICBAS-Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal.

ORCID profiles: Mariana C Almeida, Juliana Romano Lopes, Inês Costa, Renata Silva, Maria Emília Sousa, Diana I S P Resende

Funding

  • Fundação para a Ciência e a Tecnologia
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • European Commission's Recovery and Resilience Facility

Cite

APA

Almeida, M. C., Lopes, J. R., Palmeira, A., Costa, I., Silva, R., da Costa, P. M., Sousa, M. E., Dos Santos, J. L., & Resende, D. I. S. P. (2026). Boronic Chalcones as Antibacterial Adjuvants: Antibacterial Activity, Synergy With Antibiotics and Siderophore Conjugation. ChemMedChem, 21(21). https://doi.org/10.1002/cmdc.70565

Vancouver

Almeida MC, Lopes JR, Palmeira A, Costa I, Silva R, da Costa PM, et al. Boronic Chalcones as Antibacterial Adjuvants: Antibacterial Activity, Synergy With Antibiotics and Siderophore Conjugation. ChemMedChem. 2026;21(21). doi:10.1002/cmdc.70565

BibTeX
@article{Almeida2026,
  author = {Almeida, Mariana C and Lopes, Juliana Romano and Palmeira, Andreia and Costa, Inês and Silva, Renata and da Costa, Paulo M and Sousa, Maria Emília and Dos Santos, Jean Leandro and Resende, Diana I S P},
  title = {Boronic Chalcones as Antibacterial Adjuvants: Antibacterial Activity, Synergy With Antibiotics and Siderophore Conjugation},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {21},
  doi = {10.1002/cmdc.70565}
}
Start for free →